Does Ozempic Lower Libido: Current Evidence and Reported Rates
Clinical trials for semaglutide, the active ingredient in Ozempic, list decreased libido among possible adverse reactions. The FDA prescribing information for Ozempic includes sexual dysfunction as a reported side effect, based on pooled trial data submitted by Novo Nordisk. In large cardiovascular outcomes trials such as SUSTAIN-6, participants receiving semaglutide were asked about new or worsening sexual problems, and some reported lower interest in sex compared with placebo. The exact percentage varies across studies, but the label acknowledges that reduced libido can occur in a subset of users, especially during dose escalation or early treatment months. For current prescribing details, see the FDA label page for Ozempic at https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209637.
Post-marketing reports and real-world experience add further context. Healthcare professionals and patients submit adverse event data to the FDA Adverse Event Reporting System (FAERS), where decreased libido and other sexual side effects are documented for semaglutide products. These reports do not prove causation but help identify signals that warrant further study. Meta-analyses of glucagon-like peptide-1 receptor agonists, including semaglutide, have noted that gastrointestinal weight loss, appetite changes, and hormonal shifts may indirectly affect sexual desire. Researchers continue to publish updated analyses, and clinicians are advised to ask patients about sexual health when prescribing Ozempic, particularly when other risk factors such as diabetes, depression, or concurrent medications are present.
Mechanisms and Risk Factors That May Influence Sexual Side Effects
Several biological pathways could explain why Ozempic might affect libido. Semaglutide acts on GLP-1 receptors in the brain and gut, influencing appetite, insulin release, and gastric emptying. Weight loss, improved blood sugar control, and changes in gut hormones can alter energy levels, body image, and mood, all of which play a role in sexual desire. In people with type 2 diabetes, better glycemic control may reduce fatigue and neuropathy symptoms that previously dampened libido, while rapid weight loss or nutritional changes could temporarily lower sex drive in others. The balance of these effects varies by individual, baseline health, age, and concurrent conditions such as cardiovascular disease or mental health disorders.
Risk factors for experiencing sexual side effects include older age, preexisting erectile dysfunction or vaginal dryness, use of other medications that affect libido, and psychological factors such as stress or body image concerns during weight loss. Novo Nordisk advises healthcare providers to discuss potential sexual side effects before starting Ozempic and to monitor patients during treatment. The manufacturer's official medication guide lists decreased libido as a possible reaction and directs patients to report any bothersome or persistent symptoms to their prescriber. For more on prescribing and safety information, visit the Novo Nordisk Ozempic page at https://www.novonordisk.com/us-en/patient-and-caregiver-resources/ozempic.html.
Managing Low Libido While Using Ozempic
If you notice a drop in libido while taking Ozempic, first discuss it with your prescribing clinician. Doctors may evaluate whether the symptom coincides with dose changes, weight loss milestones, or other new medications. They can check for contributing issues such as low testosterone, thyroid dysfunction, depression, or vascular problems that independently affect sexual health. In some cases, adjusting the Ozempic dose, slowing the titration schedule, or switching to another diabetes or weight-management therapy may improve sexual function without sacrificing glucose control or weight-loss benefits.
Supportive steps include open communication with partners, counseling or sex therapy when psychological factors are involved, and reviewing overall lifestyle factors such as sleep, alcohol use, and exercise. The American Diabetes Association and other professional societies recommend routine screening for sexual health in people